Yaohai is a company that cares about people who are not so well. They are a set of people working round-the-clock to develop new treatments for common diseases affecting people worldwide. And one of the major health issues they are working to combat is something called HBV. It is one of the major infectious agents causing severe illness and long-term sequelae. With their research, Yaohai feels that they can help make a difference in the lives of those with this disease.
One of Yaohai's key efforts to combat HBV is a การผลิตแบคทีเรียโฟจ AP205 VLP special invention called HBsAg VLPs. Absence of a sample holder (to prevent foam formation on the top): samples are taken directly from RNs (RNA genomes; RNPs according to other established terms). These particles are similar to viruses, but they are not actual viruses, so they can’t make you sick at all. Yaohai aims for these VLPs to teach the body to recognize and better fight off the HBV virus. This is extremely exciting news in the battle against HBV!
HBsAg is a unique protein that the HBV virus can have on its outer edge. Yaohai creates HBsAg VLPs that form little nano-particles, resembling the HBV virus, but lacks all the harmful biological components that are capable of inducing infection. What this does is to allow the immune system, the body system that combats illness, to be able to recognize these HBsAg VLPs. Then, if the actual HBV attempts to enter the body, the immune system would be alert and primed to get rid of the virus.
Yaohai is working to improve the immune system response by producing HBsAg VLPs. The immune system is an army of superheroes การผลิตแบคทีเรียโฟจ Q VLP living inside the body that fight off sickness. HBsAg VLPs can be a very powerful tool to halt the disease by educating the immune system to recognize and attack the HBV virus. And this is why Yaohai thinks their work with HBsAg VLPs is so important.
Successful vaccine development for other diseases using VLPs has already taken place. Now, Yaohai is investigating whether they can use VLPs to tackle HBV as well. The best potential uses of VLPs for protection against HBV are still being revealed through very important research they are conducting. This study is a significant step to pave the way toward the application of VLPs in disease treatment.
Yaohai continues to work diligently towards gaining more insight regarding HBsAg VLPs. They are learning new ways to make these pieces that make them heftier and more efficient. In this investigation, these VLPs การผลิตวัคซีน Chimeric VLP are challenged in animals and humans to assess their efficacy against HBV. Nevertheless, every breakthrough brings hope for better therapies and a solution for those afflicted by this virus.
Yaohai Bio-Pharma, a top 10 producer of biological products, is a specialist in microbial fermentation. We have built an advanced facility that is equipped with advanced facilities as well as robust RD and manufacturing capabilities. Five drug substance production lines that are compliant with GMP standards for microbial purification and fermentation along with two automated fill and finishing lines for vials, cartridges and needles pre-filled are available. The scales for fermentation available are 100L, 500L, 1000L and 2000L. The filling volume ranges from 1ml to HBV HBsAg VLP Development. Syringes or cartridges pre-filled are filled with the equivalent of 1-3ml. Our cGMP-compliant production workshop ensures steady supply of clinical samples and commercial products. The bulk molecules produced in our factory can be shipped worldwide.
HBV HBsAg VLP Development is a leading in microbial biologics CDMO. Our focus has been on microbial-produced vaccines and therapeutics that are suited for human, veterinary, as well as pet health management. We have the most cutting-edge RD platforms and manufacturing technology which cover the entire procedure beginning with the development of microbial strains and cell banking, to process and method development, to commercial and clinical production which ensures successful delivery of innovative solutions. Over time, we have accumulated vast knowledge of microbial-based bio processing. Over 200 projects have been successfully completed, and we assist our clients to comply with regulations like those of US FDA and EU EMA. We also help them to navigate Australia TGA and China NMPA. Our professional expertise and extensive experience allows us to quickly respond to market demands and provide bespoke CDMO services.
Yaohai Bio-Pharma has experience in the manufacture of biologics derived from microorganisms. We offer tailored RD solutions and manufacturing while minimizing the risk. We have worked with diverse methods, such as HBV HBsAg VLP Development of vaccines (including peptides), growth factors, hormones, and Cytokines. We specialized in multiple microbial hosts, including yeast extracellular and intracellular (yield up to 15 g/L) bacteria periplasmic secretion, soluble intracellular, and inclusion bodies (yield up to 10 grams/L). We also have a BSL-2 fermentation platform to create bacterial vaccines. We specialize in improving processes, increasing product yields, as well as reducing production costs. We have an efficient technology team that guarantees timely and quality project delivery. This allows us to deliver your exclusive products quicker to market.
Yaohai BioPharma is a Top 10 Microbial CDMO that incorporates HBV HBsAg VLP Development as well as regulatory affairs. We have a quality management system which is in line with current GMP standards as well as global regulations. Our team of regulatory experts is proficient in global regulatory frameworks to accelerate biological launches. We ensure traceable production processes quality products, as well as complying with the rules of the US FDA and EU EMA. Australia TGA and China NMPA are also satisfied. Yaohai BioPharma has successfully passed the audit on site of the European Union's Qualified Person (QP) for our GMP quality system as well as our production facility. Furthermore, we have cleared the first certification audits of the ISO9001 Quality Management System, ISO14001 Environmental Management System, and ISO45001 Occupational Health and Safety Management System.
Yaohai Bio-Pharma ให้ความสำคัญกับโซลูชั่น CRDMO ของจุลินทรีย์มานานกว่า 14 ปี เราให้บริการด้านชีววิทยาแบบครบวงจรแก่ลูกค้าทั่วโลก
No. 801, Jiankang Avenue, Taizhou, Jiangsu, China
ลิขสิทธิ์© Yaohai Biopharmaceutical Co., Ltd. สงวนลิขสิทธิ์ | นโยบายความเป็นส่วนตัว
EN
AR
HR
CS
DA
NL
FI
FR
DE
EL
IT
JA
KO
NO
PL
PT
RO
RU
ES
SV
IW
ID
LV
LT
SR
SK
SL
UK
VI
ET
HU
TH
TR
FA
AF
MS
BE
MK
UR
BN
